• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchScopus Biopharma
    Picture of Scopus Biopharma logo

    SCPS — Scopus Biopharma News Story

    $0.000.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
      $0.02m
    • Enterprise Value
      -$1.40m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • SCPS Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    SCPS Dividends
    All News

    NASDAQ RESUMED AT 03:23 PM

    Picture of Scopus Biopharma logoScopus Biopharma
    04/08/2021 20:23
    NASDAQ RESUMED  SCPS.O  AT 03:23 PM
    

    Recent news on Scopus Biopharma

    See all news
    • Brief: Scopus Biopharma - Nasdaq Hearings Panel Informed Company, By Letter Dated December 15, Of Its Determination To Delist Co's Common Stock From Nasdaq

      16/12/2022 11:21
    • Brief: Scopus Biopharma Completes Recapitalization To Enhance Shareholder Value

      18/10/2022 14:28
    • Brief: Scopus Biopharma Says Received Additional Non-Compliance Letter From Nasdaq

      07/10/2022 22:45
    • Brief: Scopus Biopharma Received Deficiency Letter From Nasdaq

      27/05/2022 23:16
    • Brief: Scopus BioPharma Inc- On April 4, Received Deficiency Notification Letter From Nasdaq Indicating Co Was Not In Compliance With Nasdaq Listing Rule

      08/04/2022 22:21

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.